{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:49:30Z","timestamp":1790732970475,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"DOI":"10.1186\/s12911-026-03373-9","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:24:42Z","timestamp":1770650682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development and validation of a machine learning stratified prediction model for early warning of anti-tuberculosis drug-induced liver injury risk based on real-world data: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Jingyuan","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"7","key":"3373_CR1","doi-asserted-by":"publisher","first-page":"102736","DOI":"10.1016\/j.jiph.2025.102736","volume":"18","author":"SSK Akashanand","year":"2025","unstructured":"Akashanand SSK, Gaidhane S, et al. Epidemiological trends and forecasting of tuberculosis burden in the Gulf Cooperation Council countries: evidence from global burden of disease 1990\u20132021 [J]. J Infect Public Health. 2025;18(7):102736.","journal-title":"J Infect Public Health"},{"issue":"1","key":"3373_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12879-024-09079-5","volume":"24","author":"H Lv","year":"2024","unstructured":"Lv H, Zhang X, Zhang X, et al. Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019 [J]. BMC Infect Dis. 2024;24(1):243.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"3373_CR3","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1186\/s12889-024-20664-w","volume":"24","author":"H Yang","year":"2024","unstructured":"Yang H, Ruan X, Li W, et al. Global, regional, and National burden of tuberculosis and attributable risk factors for 204 countries and territories, 1990\u20132021: a systematic analysis for the global burden of diseases 2021 study [J]. BMC Public Health. 2024;24(1):3111.","journal-title":"BMC Public Health"},{"issue":"1","key":"3373_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/cid\/ciae583","volume":"81","author":"S Cheli","year":"2025","unstructured":"Cheli S, Torre A, Schiuma M, et al. NAT2 slow acetylator phenotype as a significant risk factor for hepatotoxicity caused by antituberculosis drugs: results from a multiethnic nested Case-Control study [J]. Clin Infect Dis. 2025;81(1):145\u201352.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"3373_CR5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/cpt.924","volume":"104","author":"X Hu","year":"2018","unstructured":"Hu X, Zhang M, Bai H, et al. Antituberculosis Drug-Induced adverse events in the Liver, Kidneys, and blood: clinical profiles and Pharmacogenetic predictors [J]. Clin Pharmacol Ther. 2018;104(2):326\u201334.","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"3373_CR6","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1111\/liv.14896","volume":"41","author":"F Jiang","year":"2021","unstructured":"Jiang F, Yan H, Liang L, et al. Incidence and risk factors of anti-tuberculosis drug induced liver injury (DILI): large cohort study involving 4652 Chinese adult tuberculosis patients [J]. Liver Int. 2021;41(7):1565\u201375.","journal-title":"Liver Int"},{"key":"3373_CR7","doi-asserted-by":"crossref","unstructured":"Cavaco MJ, Alcobia C, Oliveiros B, et al. Clinical and genetic risk factors for drug-induced liver injury associated with anti-tuberculosis treatment-a study from patients of Portuguese health centers [J]. J Pers Med. 2022;12(5).","DOI":"10.3390\/jpm12050790"},{"issue":"1","key":"3373_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12664-024-01643-w","volume":"44","author":"R Kumar","year":"2025","unstructured":"Kumar R, Kumar A, Patel R, et al. Incidence and risk factors of antituberculosis drug-induced liver injury in india: A systematic review and meta-analysis [J]. Indian J Gastroenterol. 2025;44(1):35\u201346.","journal-title":"Indian J Gastroenterol"},{"issue":"8","key":"3373_CR9","doi-asserted-by":"publisher","first-page":"ofad422","DOI":"10.1093\/ofid\/ofad422","volume":"10","author":"J Lim","year":"2023","unstructured":"Lim J, Kim JS, Kim HW, et al. Metabolic disorders are associated with Drug-Induced liver injury during antituberculosis treatment: A multicenter prospective observational cohort study in Korea [J]. Open Forum Infect Dis. 2023;10(8):ofad422.","journal-title":"Open Forum Infect Dis"},{"key":"3373_CR10","doi-asserted-by":"publisher","first-page":"1406454","DOI":"10.3389\/fphar.2024.1406454","volume":"15","author":"Q Liu","year":"2024","unstructured":"Liu Q, Huang L, Yan H, et al. Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury [J]. Front Pharmacol. 2024;15:1406454.","journal-title":"Front Pharmacol"},{"issue":"6","key":"3373_CR11","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/bcp.70053","volume":"91","author":"RL de Los Santos-Fernandez","year":"2025","unstructured":"de Los Santos-Fernandez RL, Segovia-Zafra A, Paz-Lopez G, et al. Epigenetic modifications in drug-induced liver injury: A systematic review [J]. Br J Clin Pharmacol. 2025;91(6):1660\u201374.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"3373_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/03602532.2023.2215478","volume":"55","author":"D Ezhilarasan","year":"2023","unstructured":"Ezhilarasan D. Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms [J]. Drug Metab Rev. 2023;55(3):239\u201353.","journal-title":"Drug Metab Rev"},{"issue":"1","key":"3373_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12931-024-02837-8","volume":"25","author":"M Li","year":"2024","unstructured":"Li M, Zhang D, Yang Q, et al. Longitudinal metabolomics of human plasma reveal metabolic dynamics and predictive markers of antituberculosis drug-induced liver injury [J]. Respir Res. 2024;25(1):254.","journal-title":"Respir Res"},{"key":"3373_CR14","doi-asserted-by":"publisher","first-page":"1512815","DOI":"10.3389\/fphar.2025.1512815","volume":"16","author":"S Pei","year":"2025","unstructured":"Pei S, Yang L, Gao H, et al. The association between the gut Microbiome and antituberculosis drug-induced liver injury [J]. Front Pharmacol. 2025;16:1512815.","journal-title":"Front Pharmacol"},{"issue":"6","key":"3373_CR15","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/cpt.1563","volume":"106","author":"C Huai","year":"2019","unstructured":"Huai C, Wei Y, Li M, et al. Genome-Wide analysis of DNA methylation and antituberculosis Drug-Induced liver injury in the Han Chinese population [J]. Clin Pharmacol Ther. 2019;106(6):1389\u201397.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"3373_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12874-024-02214-5","volume":"24","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Chen Y, Huang R, et al. Interpretable machine learning in predicting drug-induced liver injury among tuberculosis patients: model development and validation study [J]. BMC Med Res Methodol. 2024;24(1):92.","journal-title":"BMC Med Res Methodol"},{"key":"3373_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/DDDT.S495555","volume":"19","author":"Y Zeng","year":"2025","unstructured":"Zeng Y, Lu H, Li S, et al. Risk prediction of liver injury in pediatric tuberculosis treatment: development of an automated machine learning model [J]. Drug Des Devel Ther. 2025;19:239\u201350.","journal-title":"Drug Des Devel Ther"},{"issue":"7","key":"3373_CR18","doi-asserted-by":"publisher","first-page":"e29226","DOI":"10.2196\/29226","volume":"9","author":"T Zhong","year":"2021","unstructured":"Zhong T, Zhuang Z, Dong X, et al. Predicting antituberculosis Drug-Induced liver injury using an interpretable machine learning method: model development and validation study [J]. JMIR Med Inf. 2021;9(7):e29226.","journal-title":"JMIR Med Inf"},{"issue":"12","key":"3373_CR19","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/jvh.13751","volume":"29","author":"C Chou","year":"2022","unstructured":"Chou C, Veracruz N, Chitnis AS, et al. Risk of drug-induced liver injury in chronic hepatitis B and tuberculosis co-infection: A systematic review and meta-analysis [J]. J Viral Hepat. 2022;29(12):1107\u201314.","journal-title":"J Viral Hepat"},{"key":"3373_CR20","doi-asserted-by":"publisher","first-page":"110439","DOI":"10.1016\/j.cbi.2023.110439","volume":"376","author":"Y Liu","year":"2023","unstructured":"Liu Y, Chen W, Cen Y, et al. Hepatocyte ferroptosis contributes to anti-tuberculosis drug-induced liver injury: involvement of the HIF-1alpha\/SLC7A11\/GPx4 axis [J]. Chem Biol Interact. 2023;376:110439.","journal-title":"Chem Biol Interact"},{"key":"3373_CR21","doi-asserted-by":"publisher","first-page":"1037814","DOI":"10.3389\/fphar.2022.1037814","volume":"13","author":"X Zhuang","year":"2022","unstructured":"Zhuang X, Li L, Liu T, et al. Mechanisms of Isoniazid and rifampicin-induced liver injury and the effects of natural medicinal ingredients: A review [J]. Front Pharmacol. 2022;13:1037814.","journal-title":"Front Pharmacol"},{"issue":"3","key":"3373_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/JCMA.0000000000000648","volume":"85","author":"YS Huang","year":"2022","unstructured":"Huang YS, Tseng SY, Chen WW, et al. Clinical characteristics and outcomes of drug-induced liver injury in taiwan: with emphasis on the impact of chronic hepatitis B infection [J]. J Chin Med Assoc. 2022;85(3):286\u201394.","journal-title":"J Chin Med Assoc"},{"issue":"11","key":"3373_CR23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1080\/23744235.2020.1788223","volume":"52","author":"X Mo","year":"2020","unstructured":"Mo X, Xu X, Ren Z, et al. Patients with tuberculous meningitis and hepatitis B co-infection have increased risk for antituberculosis drug-induced liver injury and poor outcomes [J]. Infect Dis (Lond). 2020;52(11):793\u2013800.","journal-title":"Infect Dis (Lond)"},{"key":"3373_CR24","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3389\/fphar.2019.00853","volume":"10","author":"G Danan","year":"2019","unstructured":"Danan G, Teschke R. Roussel Uclaf causality assessment method for Drug-Induced liver injury: present and future [J]. Front Pharmacol. 2019;10:853.","journal-title":"Front Pharmacol"},{"key":"3373_CR25","doi-asserted-by":"crossref","unstructured":"Li JF, Yan LT, Yang YT, et al. Serum total bile acid is closely related to the significant liver injury in patients with non-cholestatic chronic hepatitis B virus infection: a Cross-Sectional study [J]. Clin Lab. 2020;66(8).","DOI":"10.7754\/Clin.Lab.2020.191258"},{"issue":"9","key":"3373_CR26","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/s41423-023-01026-9","volume":"20","author":"Z Xun","year":"2023","unstructured":"Xun Z, Yao X, Ou Q. Emerging roles of bile acids in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma [J]. Cell Mol Immunol. 2023;20(9):1087\u20139.","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"3373_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cll.2019.01.010","volume":"39","author":"JM Baron","year":"2019","unstructured":"Baron JM, Kurant DE, Dighe AS. Machine learning and other emerging decision support tools [J]. Clin Lab Med. 2019;39(2):319\u201331.","journal-title":"Clin Lab Med"},{"issue":"3","key":"3373_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.surg.2023.06.011","volume":"174","author":"P Kambakamba","year":"2023","unstructured":"Kambakamba P. Invited commentary: machine learning versus logistic regression for the prediction of complications after pancreatoduodenectomy [J]. Surgery. 2023;174(3):441.","journal-title":"Surgery"},{"key":"3373_CR29","doi-asserted-by":"publisher","first-page":"105307","DOI":"10.1016\/j.cmpb.2019.105307","volume":"188","author":"NH Lai","year":"2020","unstructured":"Lai NH, Shen WC, Lee CN, et al. Comparison of the predictive outcomes for anti-tuberculosis drug-induced hepatotoxicity by different machine learning techniques [J]. Comput Methods Programs Biomed. 2020;188:105307.","journal-title":"Comput Methods Programs Biomed"},{"issue":"7","key":"3373_CR30","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1021\/acs.jcim.9b00143","volume":"59","author":"C Feng","year":"2019","unstructured":"Feng C, Chen H, Yuan X, et al. Gene expression data based deep learning model for accurate prediction of Drug-Induced liver injury in advance [J]. J Chem Inf Model. 2019;59(7):3240\u201350.","journal-title":"J Chem Inf Model"},{"issue":"6","key":"3373_CR31","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1111\/bcp.15661","volume":"89","author":"MS Moosa","year":"2023","unstructured":"Moosa MS, Russomanno G, Dorfman JR, et al. Analysis of serum microRNA-122 in a randomized controlled trial of N-acetylcysteine for treatment of antituberculosis drug-induced liver injury [J]. Br J Clin Pharmacol. 2023;89(6):1844\u201351.","journal-title":"Br J Clin Pharmacol"},{"key":"3373_CR32","doi-asserted-by":"crossref","unstructured":"Jaganathan K, Tayara H, Chong KT. Prediction of drug-induced liver toxicity using SVM and optimal descriptor sets [J]. Int J Mol Sci. 2021;22(15).","DOI":"10.3390\/ijms22158073"},{"key":"3373_CR33","doi-asserted-by":"crossref","unstructured":"Wang K, Zhang L, Li L, et al. Identification of drug-induced liver injury biomarkers from multiple microarrays based on machine learning and bioinformatics analysis [J]. Int J Mol Sci. 2022;23(19).","DOI":"10.3390\/ijms231911945"},{"key":"3373_CR34","doi-asserted-by":"crossref","unstructured":"Wang Y, Xiao Q, Chen P, et al. In Silico prediction of drug-induced liver injury based on ensemble classifier method [J]. Int J Mol Sci. 2019;20(17).","DOI":"10.3390\/ijms20174106"},{"issue":"1","key":"3373_CR35","doi-asserted-by":"publisher","first-page":"e0315912","DOI":"10.1371\/journal.pone.0315912","volume":"20","author":"DA Perwitasari","year":"2025","unstructured":"Perwitasari DA, Faridah IN, Dania H, et al. Machine learning model to predict the adherence of tuberculosis patients experiencing increased levels of liver enzymes in Indonesia [J]. PLoS ONE. 2025;20(1):e0315912.","journal-title":"PLoS ONE"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-026-03373-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-026-03373-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-026-03373-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:51:35Z","timestamp":1773399095000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12911-026-03373-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3373"],"URL":"https:\/\/doi.org\/10.1186\/s12911-026-03373-9","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This single-center retrospective cohort study was conducted in accordance with the ethical principles of the Declaration of Helsinki and was approved by the Ethics Committee of Guangzhou Chest Hospital (Approval Number: KY-2024-007). Due to the retrospective nature of the study and the use of anonymized data, the requirement for informed consent was waived by the Ethics Committee of Guangzhou Chest Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study utilized retrospective, anonymized clinical data. The need for individual patient consent was waived by the ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}